IP Library Granted Patent US 9,629,985
Granted Patent B2
US 9,629,985 · App. 14/244,126 · Granted Apr 25, 2017

Drug delivery balloon apparatus and methods for use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,629,985
App. No.
14/244,126
Granted
Apr 25, 2017
Kind
B2
Abstract

A drug delivery balloon apparatus is disclosed herein, comprising: (a) at least two lumens, comprising a first lumen and a second lumen, (b) a balloon inflation port in communication with the first lumen, (c) a drug delivery port in communication with the second lumen, (d) a guidewire port in communication with either the second lumen or a third lumen, (e) an occlusion balloon, (f) a drug delivery balloon having an outer surface with a plurality of grooves, where the occlusion balloon is disposed between the drug delivery balloon and the balloon inflation port, and the occlusion and drug delivery balloons are in communication with the first lumen, (g) one or more drug delivery channels extending the length of the second lumen, and (h) one or more drug delivery ducts extending from the one or more drug delivery channels to an exterior surface of the second lumen.

Claims (33)

1. A drug delivery balloon apparatus comprising:

at least two lumens, comprising a first lumen and a second lumen;

a balloon inflation port in fluid communication with the first lumen;

a drug delivery port in fluid communication with the second lumen;

a guidewire port in fluid communication with the second lumen, wherein the second lumen is configured to receive both a guidewire and a drug solution;

an occlusion balloon;

a drug delivery balloon, wherein an outer surface of the drug delivery balloon defines a plurality of grooves each extending from a first end of the drug delivery balloon to a second end of the drug delivery balloon, wherein the plurality of grooves are spiraled, helical, or sinusoidal, wherein the occlusion balloon is disposed between the drug delivery balloon and the balloon inflation port, and wherein the occlusion balloon and the drug delivery balloon are in fluid communication with the first lumen;

one or more drug delivery channels extending the length of the second lumen; and

one or more drug delivery ducts extending from the one or more drug delivery channels to an exterior surface of the second lumen, and wherein the one or more drug delivery ducts are defined only in a portion of the second lumen that is disposed between the occlusion balloon and the drug delivery balloon.

2. The drug delivery balloon apparatus of claim 1 , wherein the plurality of grooves are axially aligned with a central axis of the drug delivery balloon.

3. The drug delivery balloon apparatus of claim 1 , wherein the occlusion balloon and the drug delivery balloon are separated from each other by a distance ranging from about 3 mm to about 5 mm.

4. The drug delivery balloon apparatus of claim 1 , wherein the drug delivery port is bifurcated.

5. The drug delivery balloon apparatus of claim 1 , wherein the occlusion balloon and the drug delivery balloon each have an inflated diameter in the range from about 2.5 mm to about 12 mm.

6. The drug delivery balloon apparatus of claim 5 , wherein the inflated diameter of the occlusion balloon ranges from about the same as the inflated diameter of the drug delivery balloon to about 2 mm larger than the inflated diameter of the drug delivery balloon.

7. The drug delivery balloon apparatus of claim 1 , wherein the occlusion balloon ranges in length from about 20 mm to about 40 mm.

8. The drug delivery balloon apparatus of claim 1 , wherein the drug delivery balloon ranges in length from about 50 mm to about 200 mm.

9. The drug delivery balloon apparatus of claim 6 , wherein the drug delivery balloon is about 200 mm in length.

10. The drug delivery balloon apparatus of claim 1 , wherein the guidewire port is sized to receive the guidewire, and wherein the guidewire has a diameter in the range of about 0.254 mm to about 0.9652 mm.

11. The drug delivery balloon apparatus of claim 1 , wherein the one or more drug delivery channels comprises four to eight channels.

12. The drug delivery balloon apparatus of claim 1 , wherein the one or more drug delivery channels is each in fluid communication with one to six drug delivery ducts of the one or more drug delivery ducts.

13. The drug delivery balloon apparatus of claim 1 , wherein the one or more drug delivery channels comprises four channels and each drug delivery channel is in fluid communication with three drug delivery ducts such that there are a total of twelve drug delivery ducts.

14. The drug delivery balloon apparatus of claim 1 , wherein a diameter of the second lumen is greater than a diameter of the guidewire from a location between the guidewire port and the drug delivery port until the one or more drug delivery ducts, and wherein the diameter of the second lumen is approximately equal to the diameter of the guidewire from a location between distal to the one or more drug delivery ducts and the distal end of the drug delivery balloon.

15. The drug delivery balloon apparatus of claim 1 , further comprising a flange or one-way valve positioned at the guidewire port.

16. A method for administering at least one drug to a subject in need thereof using a drug delivery balloon apparatus, the method comprising:

introducing the drug delivery balloon apparatus of claim 1 into a target passage;

inflating the occlusion balloon and the drug delivery balloon;

injecting a drug solution into the drug delivery port; and

advancing the drug solution through the second lumen to the one or more drug delivery ducts into the target passage in the subject and then into and along a plurality of grooves defined in an outer surface of the drug delivery balloon.

17. The method of claim 16 , wherein injecting the drug solution is performed at a fluid pressure at or below 2 atm.

18. The method of claim 16 , wherein the inflated diameter of the occlusion balloon ranges from about the same as the inflated diameter of the drug delivery balloon to about 2 mm larger than the inflated diameter of the drug delivery balloon.

19. The method of claim 16 , wherein inflating the occlusion balloon and the drug delivery balloon comprises:

injecting a saline contrast mixture into the balloon inflation port; and

advancing the saline contrast mixture through one of the at least two lumens to the occlusion balloon and the drug delivery balloon.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2015
From: KELLY, PATRICK W.
To: SANFORD HEALTH
Reel/Frame 036322/0494 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2014
From: KELLY, PATRICK W., DR.
To: SANFORD HEALTH
Reel/Frame 032724/0780 →